A detailed history of Carmichael Hill & Associates, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Carmichael Hill & Associates, Inc. holds 1,381 shares of VTRS stock, worth $17,953. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,381
Previous 1,434 3.7%
Holding current value
$17,953
Previous $15,000 6.67%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$10.32 - $12.13 $546 - $642
-53 Reduced 3.7%
1,381 $16,000
Q2 2024

Aug 02, 2024

BUY
$10.05 - $12.02 $1,819 - $2,175
181 Added 14.45%
1,434 $15,000
Q1 2024

Apr 24, 2024

SELL
$11.27 - $13.53 $135 - $162
-12 Reduced 0.95%
1,253 $14,000
Q4 2023

Jan 23, 2024

BUY
$8.77 - $10.85 $491 - $607
56 Added 4.63%
1,265 $13,000
Q3 2023

Oct 30, 2023

BUY
$9.59 - $11.35 $508 - $601
53 Added 4.58%
1,209 $11,000
Q2 2023

Aug 04, 2023

BUY
$9.02 - $10.29 $902 - $1,029
100 Added 9.47%
1,156 $11,000
Q1 2023

Apr 05, 2023

BUY
$9.2 - $12.26 $423 - $563
46 Added 4.55%
1,056 $10,000
Q4 2022

Feb 13, 2023

BUY
$8.72 - $11.56 $8 - $11
1 Added 0.1%
1,010 $11,000
Q3 2022

Nov 10, 2022

BUY
$8.48 - $11.13 $848 - $1,113
100 Added 11.0%
1,009 $9,000
Q2 2022

Aug 05, 2022

BUY
$9.95 - $12.27 $1,243 - $1,533
125 Added 15.94%
909 $10,000
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $186 - $292
19 Added 2.48%
784 $9,000
Q4 2021

Jan 31, 2022

SELL
$12.09 - $14.68 $1,571 - $1,908
-130 Reduced 14.53%
765 $10,000
Q3 2021

Nov 12, 2021

SELL
$13.25 - $15.13 $2,756 - $3,147
-208 Reduced 18.86%
895 $12,000
Q2 2021

Aug 03, 2021

SELL
$12.97 - $16.15 $1,348 - $1,679
-104 Reduced 8.62%
1,103 $16,000
Q1 2021

Apr 28, 2021

SELL
$13.59 - $18.54 $5,055 - $6,896
-372 Reduced 23.56%
1,207 $17,000
Q4 2020

Jan 27, 2021

BUY
$14.3 - $18.74 $22,579 - $29,590
1,579 New
1,579 $30,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Carmichael Hill & Associates, Inc. Portfolio

Follow Carmichael Hill & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmichael Hill & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Carmichael Hill & Associates, Inc. with notifications on news.